Quantcast

Latest Drug Development Stories

2014-07-21 23:06:38

GIA initiates research coverage on the global “Pediatric Drugs and Vaccines” market, as part of its ongoing multiple research projects on diverse industries and markets. The soon to be released report identifies rising incidence of metabolic conditions, cardiovascular and CNS diseases among children, rising per capita healthcare spends in emerging markets and a strong drug development pipeline, as primary growth drivers in the market. San Jose, California (PRWEB) July 21, 2014 Follow...

2014-07-21 08:29:00

LONDON, July 21, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: Cell Culture Market by Equipment (Bioreactor, Incubator, Centrifuge), by Reagent (Media, Sera, Growth Factors, Serum Free Media), by Application (Cancer Research, Gene Therapy, Drug Development, Vaccine Production, Toxicity Testing) - Global Forecast to...

2014-07-16 12:28:25

Cognitive function is primary endpoint COPENHAGEN, Denmark, July 16, 2014 /PRNewswire/ -- Bracket is pleased to announce that Biotie Therapies, a specialized drug development company focusing on products for neurodegenerative and psychiatric disorders, has selected the CDR System for use as the primary endpoint for their phase 2 trial of SYN120, an orally administered, dual 5HT6/5HT2a antagonist. SYN120 is in development for the treatment of Parkinson's disease and other cognitive...

2014-07-14 23:04:05

Key Questions & Memorable Quotes from #eCongress Toronto, Canada (PRWEB) July 14, 2014 Throughout this past June 100s of mid-to-senior level executives from across the clinical trials space, representing 38 countries globally, registered for Xtalks 1st Annual eCongress webinar series entitled “Optimizing Patient Participation in Clinical Trials. Attract. Engage. Retain.” This well-attended eCongress kicked off with internationally renowned R&D expert, Ken Getz, of Tufts CSDD,...

2014-07-11 16:23:25

FALLS CHURCH, Va., July 11, 2014 /PRNewswire/ -- Poor bioavailability is a major reason for compounds to fail in preclinical development. Technology Catalysts International (TCI), a leading global pharmaceutical consulting firm, has compiled and analyzed technical and market information pertaining to the delivery of poorly water soluble or poorly permeable pharmaceutical compounds. Due to the complex nature of a multitude of existing as well as newly-discovered active ingredients,...

2014-07-10 10:28:40

Boston Children's Hospital Study calls for more focus on long-term outcomes in pediatric trials of drugs intended for chronic use Over the last 60 years, the U.S. Food and Drug Administration (FDA) approved 20 medications for attention deficit/hyperactivity disorder (ADHD) based on clinical trials that were not designed to study their long-term efficacy and safety or to detect rare adverse events, researchers at Boston Children's Hospital report today in PLOS ONE. The study highlights...

2014-07-09 23:06:43

Dr. Srivastava is Director of Technical Services and Clinical Research primarily for companion animals. Menomonie, Wis. (PRWEB) July 09, 2014 Vets Plus, Inc. is pleased to announce Dr. Ajay Srivastava, DVM, Ph.D. has joined the Research and Development team as Director of Technical Services and Clinical Research. Dr. Srivastava will focus on research for companion animals. Dr. Srivastava was most recently Senior Research Scientist of the Anticonvulsant Drug Development Program at the...

2014-07-09 16:28:10

Study calls for more focus on long-term outcomes in pediatric trials of drugs intended for chronic use BOSTON, July 9, 2014 /PRNewswire-USNewswire/ -- Over the last 60 years, the U.S. Food and Drug Administration (FDA) approved 20 medications for attention deficit/hyperactivity disorder (ADHD) based on clinical trials that were not designed to study their long-term efficacy and safety or to detect rare adverse events, researchers at Boston Children's Hospital report today in PLOS...

2014-07-09 12:30:16

LONDON, July 9, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Induced Pluripotent Stem Cells : Global Marketshttps://www.reportbuyer.com/product/2212008/Induced-Pluripotent-Stem-Cells--Global-Markets.html This BCC Research report provides detailed market and industry analyses to help readers quantify and qualify the global market for induced pluripotent stem cells (iPSCs). Important trends of the field and market segments are identified, and market sizes...

2014-07-03 12:39:55

Cleveland Clinic Analysis of clinical trials shows pipeline for therapeutics is small; 99.6 percent of drug attempts fail Researchers at the Cleveland Clinic Lou Ruvo Center for Brain Health have conducted the first-ever analysis of clinical trials for Alzheimer's disease (AD), revealing an urgent need to increase the number of agents entering the AD drug development pipeline and progressing successfully towards new therapy treatments. The paper, "Alzheimer's Disease Drug Development...


Word of the Day
penuche
  • A fudgelike confection of brown sugar, cream or milk, and chopped nuts.
'Penuche' is a variant of 'panocha,' a coarse grade of sugar made in Mexico. 'Panocha' probably comes from the Spanish 'panoja, panocha,' ear of grain.
Related